HASF is a stem cell paracrine factor that activates PKC epsilon mediated cytoprotection

Journal of Molecular and Cellular Cardiology

Volumn 66, Issue , 2014, Pages 157-164

  Huang, Jing ^a   Guo, Jian ^a   Beigi, Farideh ^a   Hodgkinson, Conrad P ^a   Facundo, Heberty T ^a   Zhang, Zhiping ^a   Espinoza Derout, Jorge ^a   Zhou, Xiyou ^a   Pratt, Richard E ^a   Mirotsou, Maria ^a   Dzau, Victor J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cytoprotection; Ischemia; Mesenchymal stem cell; Paracrine; PKC epsilon

Indexed keywords

CASPASE; HYPOXIA AND AKT INDUCED STEM CELL FACTOR; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PROTEIN KINASE C EPSILON; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; IN VITRO STUDY; MESENCHYMAL STEM CELL; MOUSE; NICK END LABELING; NONHUMAN; OPEN READING FRAME; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; REPERFUSION INJURY;

CYTOPROTECTION; ISCHEMIA; MESENCHYMAL STEM CELL; PARACRINE; PKC EPSILON;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CYTOPROTECTION; GENE EXPRESSION REGULATION; HUMANS; IN SITU NICK-END LABELING; MEMBRANE PROTEINS; MICE; MITOCHONDRIA; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PARACRINE COMMUNICATION; PROTEIN KINASE C-EPSILON; SIGNAL TRANSDUCTION;

EID: 84891681942     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.11.010     Document Type: Article

References (26)

1. Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., De Simone G., et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010, 121:e46-e215.
2. Yellon D.M., Hausenloy D.J. Myocardial reperfusion injury. N Engl J Med 2007, 357:1121-1135.
3. Baraniak P.R., McDevitt T.C. Stem cell paracrine actions and tissue regeneration. Regen Med 2010, 5:121-143.
4. Kim S.U., de Vellis J. Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res 2009, 87:2183-2200.
5. Mirotsou M., Jayawardena T.M., Schmeckpeper J., Gnecchi M., Dzau V.J. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol 2011, 50:280-289.
6. Passier R., van Laake L.W., Mummery C.L. Stem-cell-based therapy and lessons from the heart. Nature 2008, 453:322-329.
7. Hodgkinson C.P., Gomez J.A., Mirotsou M., Dzau V.J. Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther 2010, 21:1513-1526.
8. Beigi F., Schmeckpeper J., Pow-Anpongkul P., Payne J.A., Zhang L., Zhang Z., et al. C3orf58, a novel paracrine protein, stimulates cardiomyocyte cell cycle Progression through the PI3K-AKT-CDK7 pathway. Circ Res 2013, 113:372-380.
9. Subramaniam A., Jones W.K., Gulick J., Wert S., Neumann J., Robbins J. Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J Biol Chem 1991, 266:24613-24620.
10. Mirotsou M., Zhang Z., Deb A., Zhang L., Gnecchi M., Noiseux N., et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci U S A 2007, 104:1643-1648.
11. Gnecchi M., He H., Liang O.D., Melo L.G., Morello F., Mu H., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005, 11:367-368.
12. Gnecchi M., He H., Melo L.G., Noiseaux N., Morello F., de Boer R.A., et al. Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells 2009, 27:971-979.
13. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008, 103:1204-1219.
14. Lee Y., Gustafsson A.B.. Role of apoptosis in cardiovascular disease. Apoptosis 2009, 14:536-548.
15. Kinnally K.W., Antonsson B. A tale of two mitochondrial channels, MAC and PTP, in apoptosis. Apoptosis 2007, 12:857-868.
16. Duquesnes N., Lezoualc'h F., Crozatier B. PKC-delta and PKC-epsilon: foes of the same family or strangersα. J Mol Cell Cardiol 2011, 51:665-673.
17. Sivaraman V., Hausenloy D.J., Kolvekar S., Hayward M., Yap J., Lawrence D., et al. The divergent roles of protein kinase C epsilon and delta in simulated ischaemia-reperfusion injury in human myocardium. J Mol Cell Cardiol 2009, 46:758-764.
18. Palaniyandi S.S., Sun L., Ferreira J.C., Mochly-Rosen D. Protein kinase C in heart failure: a therapeutic targetα. Cardiovasc Res 2009, 82:229-239.
19. Inagaki K., Churchill E., Mochly-Rosen D. Epsilon protein kinase C as a potential therapeutic target for the ischemic heart. Cardiovasc Res 2006, 70:222-230.
20. Takahashi M., Li T.S., Suzuki R., Kobayashi T., Ito H., Ikeda Y., et al. Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am J Physiol Heart Circ Physiol 2006, 291:H886-H893.
21. Hinkel R., El-Aouni C., Olson T., Horstkotte J., Mayer S., Muller S., et al. Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection. Circulation 2008, 117:2232-2240.
22. Budas G.R., Mochly-Rosen D. Mitochondrial protein kinase Cepsilon (PKCepsilon): emerging role in cardiac protection from ischaemic damage. Biochem Soc Trans 2007, 35:1052-1054.
23. Dave K.R., DeFazio R.A., Raval A.P., Torraco A., Saul I., Barrientos A., et al. Ischemic preconditioning targets the respiration of synaptic mitochondria via protein kinase C epsilon. J Neurosci 2008, 28:4172-4182.
24. Churchill E., Budas G., Vallentin A., Koyanagi T., Mochly-Rosen D. PKC isozymes in chronic cardiac disease: possible therapeutic targetsα. Annu Rev Pharmacol Toxicol 2008, 48:569-599.
25. Takatalo M., Jarvinen E., Laitinen S., Thesleff I., Ronnholm R. Expression of the novel Golgi protein GoPro49 is developmentally regulated during mesenchymal differentiation. Dev Dyn 2008, 237:2243-2255.
26. Galli D., Gobbi G., Carrubbi C., Di Marcantonio D., Benedetti L., De Angelis M.G., et al. The role of PKCepsilon-dependent signaling for cardiac differentiation. Histochem Cell Biol 2013, 139:35-46.